6881 - 6890 of 7730 Results
Title
Year
-
RESTRICTEDTitle: Parkinson’s disease: what role do pedunculopontine cholinergic neurons play?Journal Name: Future NeurologyPublisher: Informa UK LimitedVol: 9Issue #: 1Start Page: 5End Page: 8Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/fnl.13.61Best OA location URL: https://europepmc.org/articles/pmc5568855?pdf=renderCitation Count: 6
- Peripheral Administration of the Selective Inhibitor of Soluble Tumor Necrosis Factor (TNF) XPro®1595 Attenuates Nigral Cell Loss and Glial Activation in 6-OHDA Hemiparkinsonian Rats2014RESTRICTEDTitle: Peripheral Administration of the Selective Inhibitor of Soluble Tumor Necrosis Factor (TNF) XPro®1595 Attenuates Nigral Cell Loss and Glial Activation in 6-OHDA Hemiparkinsonian RatsJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 4Issue #: 3Start Page: 349End Page: 360Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-140410Best OA location URL: https://europepmc.org/articles/pmc4154985?pdf=renderCitation Count: 75
-
RESTRICTEDTitle: REM Sleep Behavior and Motor Findings in Parkinson's Disease: A Cross-sectional Analysis.Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.7916/d84b2zdfCitation Count: 4
- Risky driving and pedunculopontine nucleus-thalamic cholinergic denervation in Parkinson disease2014RESTRICTEDTitle: Risky driving and pedunculopontine nucleus-thalamic cholinergic denervation in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 1Start Page: 13End Page: 16Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2013.08.021Best OA location URL: https://europepmc.org/articles/pmc3946835?pdf=renderCitation Count: 8
-
RESTRICTEDTitle: Select E2 enzymes differentially regulate parkin activation and mitophagyJournal Name: Journal of Cell SciencePublisher: The Company of BiologistsVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1242/jcs.147520Best OA location URL: https://jcs.biologists.org/content/joces/127/16/3488.full.pdfCitation Count: 61
-
RESTRICTEDTitle: Tardive Dyskinesia: Therapeutic Options for an Increasingly Common DisorderJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 11Issue #: 1Start Page: 166End Page: 176Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-013-0222-5Best OA location URL: https://europepmc.org/articles/pmc3899488?pdf=renderCitation Count: 91
- Temporal Characteristics of High-Frequency Lower-Limb Oscillation during Freezing of Gait in Parkinson’s Disease2014RESTRICTEDTitle: Temporal Characteristics of High-Frequency Lower-Limb Oscillation during Freezing of Gait in Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2014Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1155/2014/606427Best OA location URL: https://downloads.hindawi.com/journals/pd/2014/606427.pdfCitation Count: 21
- The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants2014RESTRICTEDTitle: The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variantsJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 1Start Page: 266.e5End Page: 266.e14Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2013.07.013Best OA location URL: https://research-repository.griffith.edu.au/bitstream/10072/67208/1/MellickPUB29.pdfCitation Count: 31
- Therapeutic Development Paths for Cognitive Impairment in Parkinson's Disease: Report of a Regulatory Roundtable2014RESTRICTEDTitle: Therapeutic Development Paths for Cognitive Impairment in Parkinson's Disease: Report of a Regulatory RoundtableJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 4Issue #: 4Start Page: 585End Page: 589Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-140385Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd140385?id=journal-of-parkinsons-disease%2Fjpd140385Citation Count: 16
-
RESTRICTEDTitle: Therapy for Parkinson’s Disease: What is in the Pipeline?Journal Name: NeurotherapeuticsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 24End Page: 33Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-013-0242-1Best OA location URL: https://europepmc.org/articles/pmc3899489?pdf=renderCitation Count: 20